These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1361798)

  • 1. The modulation by fresh and spent peritoneal dialysis fluids of antibiotic kinetics directed against Staphylococcus epidermidis biofilms.
    Richards GK; Kostiner GB; Gagnon RF
    Adv Perit Dial; 1992; 8():246-9. PubMed ID: 1361798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of dialysis fluid on the susceptibility of Staphylococcus epidermidis biofilms to rifampin.
    Gagnon RF; Richards GK; Kostiner GB; Morcos R
    Adv Perit Dial; 1993; 9():183-6. PubMed ID: 8105919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic activity against Staphylococcus epidermidis biofilms in dialysis fluids.
    Richards GK; Prentis J; Gagnon RF
    Adv Perit Dial; 1989; 5():133-7. PubMed ID: 2577396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
    Gagnon RF; Richards GK; Kostiner GB
    Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of peritoneal dialysis solutions on rifampin action against Staphylococcus epidermidis in the fluid and biofilm phases of growth.
    Richards GK; Gagnon RF; Obst G; Kostiner GB
    Perit Dial Int; 1993; 13 Suppl 2():S341-4. PubMed ID: 8399605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms.
    Gualtieri M; Bastide L; Villain-Guillot P; Michaux-Charachon S; Latouche J; Leonetti JP
    J Antimicrob Chemother; 2006 Oct; 58(4):778-83. PubMed ID: 16880176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
    Richards GK; Morcos RJ; Gagnon RF
    Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin activity against Staphylococcus epidermidis biofilms.
    Obst G; Gagnon RF; Prentis J; Richards GK
    ASAIO Trans; 1988; 34(3):782-4. PubMed ID: 3196598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modulation of rifampin action against Staphylococcus epidermidis biofilms by drug additives to peritoneal dialysis solutions.
    Gagnon RF; Richards GK; Obst G
    Perit Dial Int; 1993; 13 Suppl 2():S345-7. PubMed ID: 8399606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of heparin on rifampin activity against Staphylococcus epidermidis biofilms.
    Gagnon RF; Harris AD; Prentis J; Richards GK
    Adv Perit Dial; 1989; 5():138-42. PubMed ID: 2577397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
    Lee JY; Ko KS; Peck KR; Oh WS; Song JH
    J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assay to measure antibiotic efficacy against Staphylococcus epidermidis biofilms on implant surfaces.
    Richards GK; Gagnon RF; Morcos RJ
    ASAIO J; 1994; 40(3):M570-5. PubMed ID: 8555579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of slime dispersants and anti-adhesives on in vitro biofilm formation of Staphylococcus epidermidis on intraocular lenses and on antibiotic activities.
    Kadry AA; Fouda SI; Shibl AM; Abu El-Asrar AA
    J Antimicrob Chemother; 2009 Mar; 63(3):480-4. PubMed ID: 19147522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of rifampin and analogs against Staphylococcus epidermidis biofilms in a CAPD environment model.
    Obst G; Gagnon RF; Harris A; Prentis J; Richards GK
    Am J Nephrol; 1989; 9(5):414-20. PubMed ID: 2801789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters.
    García I; Conejo Mdel C; Ojeda A; Rodríguez-Baño J; Pascual A
    J Microbiol Methods; 2010 Dec; 83(3):307-11. PubMed ID: 20888868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm.
    Villain-Guillot P; Gualtieri M; Bastide L; Leonetti JP
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3117-21. PubMed ID: 17606690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC; Simon M
    Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative rates of antibiotic action against Staphylococcus epidermidis biofilms.
    Richards GK; Gagnon RF; Prentis J
    ASAIO Trans; 1991; 37(3):M160-2. PubMed ID: 1751091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids.
    Zelenitsky S; Franczuk C; Fine A; Ariano R; Harding G
    J Antimicrob Chemother; 2002 May; 49(5):863-6. PubMed ID: 12003985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
    Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.